TY - JOUR
T1 - Community Health Centers’ Performance in Cancer Screening and Prevention
AU - Huguet, Nathalie
AU - Hodes, Tahlia
AU - Holderness, Heather
AU - Bailey, Steffani R.
AU - DeVoe, Jennifer E.
AU - Marino, Miguel
N1 - Funding Information:
This work was supported by the National Cancer Institute of NIH (Grant Number P50CA244289 ). This P50 program was launched by the National Cancer Institute as part of the Cancer Moonshot.
Funding Information:
The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of NIH. This work was supported by the National Cancer Institute of NIH (Grant Number P50CA244289). This P50 program was launched by the National Cancer Institute as part of the Cancer Moonshot. No financial disclosures were reported by the authors of this paper. Nathalie Huguet: Conceptualization; Funding acquisition; Methodology; Supervision; Validation; Visualization; Writing - original draft. Tahlia Hodes: Conceptualization; Data curation; Formal analysis; Methodology; Validation; Writing - original draft. Heather Holderness: Conceptualization; Project administration; Resources; Supervision; Writing - original draft. Steffani R. Bailey: Writing - original draft. Jennifer E. DeVoe: Funding acquisition; Writing - original draft. Miguel Marino: Conceptualization; Data curation; Formal analysis; Methodology; Supervision; Validation; Visualization; Writing - original draft.
Publisher Copyright:
© 2021 American Journal of Preventive Medicine
PY - 2022/2
Y1 - 2022/2
N2 - Introduction: Little is known about what clinic-level factors differentiate community health centers that achieve high performance on cancer-preventive care metrics. This study aims to describe the longitudinal trends in the delivery of 3 cancer-preventive care metrics (cervical and colorectal cancer screenings and tobacco-cessation intervention) and define and compare community health centers with high cancer-preventive care performance with those with low cancer-preventive care performance. Methods: This observational study used 2012–2019 community health center data (N=933) from the Uniform Data System. High/low performance was based on Healthy People 2020 targets and sample distribution. For each cancer-preventive care metric, the percentage of community health centers that met high (≥70.5% at cervical or colorectal cancer screening or >80% tobacco-cessation intervention) and low thresholds at 1, 2, and all the 3 screenings was estimated. Multivariable generalized estimating equations logistic regression modeling was used to assess the community health center‒level factors associated with screening performance. Results: The community health centers’ performance for tobacco-cessation intervention remained at ≥80%, with a small increase over time. Performance for cervical cancer screening remained unchanged with about 50% of patients screened. Colorectal cancer screening performance increased from around 30% in 2012 to 44% in 2019. Very few community health centers reached high performance (3%) in all the 3 indicators, and 13% of community health centers were high in any 2 of the outcomes in 2019. Higher patient volume, a greater proportion of Hispanic patients, fewer uninsured patients, and community health centers located in the Northeast region were associated with high performance in 2019. Conclusions: Very few community health centers meet all Healthy People 2020 goals in cancer screenings and may struggle to achieve the 2030 goals. Very few indicators differentiated high performers from low performers.
AB - Introduction: Little is known about what clinic-level factors differentiate community health centers that achieve high performance on cancer-preventive care metrics. This study aims to describe the longitudinal trends in the delivery of 3 cancer-preventive care metrics (cervical and colorectal cancer screenings and tobacco-cessation intervention) and define and compare community health centers with high cancer-preventive care performance with those with low cancer-preventive care performance. Methods: This observational study used 2012–2019 community health center data (N=933) from the Uniform Data System. High/low performance was based on Healthy People 2020 targets and sample distribution. For each cancer-preventive care metric, the percentage of community health centers that met high (≥70.5% at cervical or colorectal cancer screening or >80% tobacco-cessation intervention) and low thresholds at 1, 2, and all the 3 screenings was estimated. Multivariable generalized estimating equations logistic regression modeling was used to assess the community health center‒level factors associated with screening performance. Results: The community health centers’ performance for tobacco-cessation intervention remained at ≥80%, with a small increase over time. Performance for cervical cancer screening remained unchanged with about 50% of patients screened. Colorectal cancer screening performance increased from around 30% in 2012 to 44% in 2019. Very few community health centers reached high performance (3%) in all the 3 indicators, and 13% of community health centers were high in any 2 of the outcomes in 2019. Higher patient volume, a greater proportion of Hispanic patients, fewer uninsured patients, and community health centers located in the Northeast region were associated with high performance in 2019. Conclusions: Very few community health centers meet all Healthy People 2020 goals in cancer screenings and may struggle to achieve the 2030 goals. Very few indicators differentiated high performers from low performers.
UR - http://www.scopus.com/inward/record.url?scp=85117403573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85117403573&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2021.07.007
DO - 10.1016/j.amepre.2021.07.007
M3 - Article
C2 - 34663549
AN - SCOPUS:85117403573
SN - 0749-3797
VL - 62
SP - e97-e106
JO - American journal of preventive medicine
JF - American journal of preventive medicine
IS - 2
ER -